Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
Portfolio Pulse from Avi Kapoor
Wall Street analysts have updated their price targets and ratings for several US-listed companies, including ACADIA Pharmaceuticals, Asana, Micron Technology, NIKE, SentinelOne, Hyatt Hotels, Vaxcyte, Oracle, EQT Corporation, and Dollar General. The adjustments reflect a mix of upgrades and downgrades, with notable mentions such as Oracle's price target being raised from $140 to $160 by Mizuho, and Dollar General's price target increased from $120 to $158 by JP Morgan.

March 12, 2024 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Oppenheimer cut ACADIA Pharmaceuticals' price target from $25 to $19, maintaining a Perform rating.
A reduction in price target by a reputable analyst firm like Oppenheimer could lead to short-term negative sentiment among investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
HSBC lowered Asana's price target from $18 to $16, with a Reduce rating.
A lower price target and a Reduce rating from HSBC may negatively impact Asana's stock in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Baird raised Hyatt Hotels' price target from $150 to $160, maintaining a Neutral rating.
An increase in price target with a Neutral rating presents mixed signals, likely resulting in a neutral short-term impact on Hyatt Hotels.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Morgan Stanley slightly cut NIKE's price target from $125 to $124, but maintained an Overweight rating.
A minor adjustment in NIKE's price target with a continued positive rating suggests a neutral short-term impact.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
JP Morgan upgraded Dollar General's price target from $120 to $158 and changed the rating from Underweight to Neutral.
An upgrade in both rating and price target by JP Morgan suggests a positive short-term outlook for Dollar General.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
B of A Securities raised EQT Corporation's price target from $52 to $60, maintaining a Buy rating.
An increase in price target with a positive rating could lead to short-term bullish sentiment for EQT Corporation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Wedbush raised Micron Technology's price target from $95 to $103, maintaining an Outperform rating.
An increase in price target and a positive rating from Wedbush could lead to short-term bullish sentiment for Micron Technology.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Mizuho boosted Oracle's price target from $140 to $160, with a Buy rating.
A significant price target increase and a Buy rating from Mizuho indicate a strong short-term bullish outlook for Oracle.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Mizuho significantly raised Vaxcyte's price target from $69 to $113, maintaining a Buy rating.
A substantial increase in price target with a Buy rating from Mizuho suggests strong short-term bullish sentiment for Vaxcyte.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Wedbush increased SentinelOne's price target from $28 to $32, with an Outperform rating.
An increased price target and positive rating from Wedbush could lead to short-term positive momentum for SentinelOne.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80